Shortages of name-brand obesity drugs like Wegovy and Zepbound led to a boom in compounded alternatives sold online. In a recent NPR report, AACE President Scott D. Isaacs, MD, FACP, FACE, cautioned…
CGM Device Comparison
Compare and contrast FDA-approved CGM systems to find what is right for each individual patient and your practice.
FDA Early Alert: FreeStyle Libre 3…
Watch this MedPage Today video with AACE President Scott D. Isaacs, MD, FACP, FACE, as he recaps key takeaways from the 2025 AACE Annual Meeting. He highlights a standout keynote by Dr. Jacqueline…
On June 5–6, the Global Think-tank on Steatotic Liver Disease convened a multidisciplinary group of 125 participants in Barcelona, including clinicians, patient advocates, public health experts, and…
It's okay for your liver to have a little fat. But if more than 5% of your liver's weight is fat, you have MASLD, which stands for metabolic dysfunction–associated steatotic liver…
Emerging screening methods may support earlier diagnosis and intervention in thyroid eye disease (TED) care. In a recent MedCentral article, AACE President Scott D. Isaacs, MD, FACP, FACE, explains…
In this Wall Street Journal feature, AACE President Scott D. Isaacs, MD, FACP, FACE, offers expert insight into the growing use of personalized nutrition tools like microbiome tests and continuous…
Tirzepatide (TZP) was associated with improved metabolic parameters and gonadal hormone levels in male patients with obesity and metabolic hypogonadism, according to findings of an Italian pilot…
Thyroid disorders and menopause can share many overlapping midlife symptoms, often described as “nonspecific,” making it difficult to determine the underlying cause. AACE President Scott D. Isaacs,…